Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday, 5 June 2017

Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma.

Stephen Stuckey et al. published in the Journal of Clinical Neuroscience.

Read article here.

No comments:

Post a Comment